POSEIDA THERAPEUTICSCS INC
POSEIDA THERAPEUTICSCS INC
Share · US73730P1084 · PSTX · A2PEYK (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - 0,00 % 0,00 % 1,92 % 244,40 % -37,85 %

Company Profile for POSEIDA THERAPEUTICSCS INC Share

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC). It is also developing P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; and P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, ovarian, and other epithelial-derived cancers. In addition, the company engages in the development of P-CD19CD20-ALLO1 for B cell malignancies and other autoimmune diseases; and P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for multiple myeloma. Further, it is developing P-PSMA-ALLO1, an allogeneic CAR-T product candidate for treating mCRPC. Additionally, the company engages in the development of P-OTC-101 and P-FVIII-101 that are clinical stage liver-directed gene therapies; and other allogeneic dual CAR candidates. It has a research collaboration and license agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2014 and is headquartered in San Diego, California.

Invested Funds

The following funds have invested in: POSEIDA THERAPEUTICSCS INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
16,28
Percentage (%)
0,04 %

Company Data

Name POSEIDA THERAPEUTICSCS INC
Company Poseida Therapeutics, Inc.
Symbol PSTX
Website https://www.poseida.com
Primary Exchange XNAS NASDAQ
WKN A2PEYK
ISIN US73730P1084
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Mark J. Gergen J.D.
Market Capitalization 926 Mio
Country United States of America
Currency USD
Employees 0,4 T
Address 9390 Towne Centre Drive, 92121 San Diego
IPO Date 2020-07-10

Ticker Symbols

Name Symbol
Frankfurt 2RZ.F
NASDAQ PSTX

More Shares

Investors who POSEIDA THERAPEUTICSCS INC hold also have the following shares in their portfolio:
ACTIVISION BLIZZARD INC
ACTIVISION BLIZZARD INC Share
ADTRAN HOLDINGS INC
ADTRAN HOLDINGS INC Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
BITCOIN
BITCOIN Crypto
BROADCO INC
BROADCO INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTAMARE INC
COSTAMARE INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EPIROC AB B
EPIROC AB B Share
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
RH Tactical Rotation ETF
RH Tactical Rotation ETF ETF
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025